Renhe Pharmacy Co.,Ltd (SHE:000650)
China flag China · Delayed Price · Currency is CNY
5.34
-0.07 (-1.29%)
Sep 10, 2026, 2:10 PM CST

Renhe Pharmacy Co.,Ltd Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
458.16393.21481.91567.26574.43665.02
Depreciation & Amortization
116.66115.25122.65141.7117.1586.64
Other Amortization
2.983.972.845.456.585.5
Loss (Gain) From Sale of Assets
-0.01-2.05-1.370.27-0.34-16.84
Asset Writedown & Restructuring Costs
90.01119.52105.01207.6332.421.44
Loss (Gain) From Sale of Investments
-97.11-108.55-88.74-76.09-68.43-31.45
Provision & Write-off of Bad Debts
23.8832.5428.613.926.672.42
Other Operating Activities
47.6104.693.2180.17173.97140.89
Change in Accounts Receivable
21.26178.96149.68-118.15127.1-62.47
Change in Inventory
51.67-49.237.719.78111.63-124.42
Change in Accounts Payable
59.7778.31-353.64-313.28182.28101.35
Change in Other Net Operating Assets
-23.66-15.5315.53-17.3210.39
Operating Cash Flow
752.3851.31557.26499.471,270777.72
Operating Cash Flow Growth
-13.33%52.77%11.57%-60.67%63.30%-12.30%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-53.22-74.59-285.72-186.55-221.09-499.78
Sale of Property, Plant & Equipment
0.330.368.952.020.2922.63
Cash Acquisitions
-0.04-0.06----704.65
Divestitures
----15.78-
Investment in Securities
-215.33-138.41-268.3-187.49-413.661,472
Other Investing Activities
109.19114.4182.6377.9743.5228.93
Investing Cash Flow
-159.06-98.29-462.44-294.04-575.17319.26

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Repaid
------60
Long-Term Debt Repaid
--0.79-5.89-7.07-5.55-3.55
Lease Payments
-0.79-0.79-5.89-7.07-5.55-3.55
Total Debt Repaid
-0.79-0.79-5.89-7.07-5.55-63.55
Net Debt Issued (Repaid)
-0.79-0.79-5.89-7.07-5.55-63.55
Issuance of Common Stock
2.332.33---139.75
Repurchase of Common Stock
---39.93-60.08--199.64
Common Dividends Paid
-0.83-210.48-279.93-279.42-140.17-283.22
Other Financing Activities
-190.21-95.67-58.03-69.49-84.36-55.53
Financing Cash Flow
-189.5-304.62-383.78-416.06-230.08-462.19

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.05-0.01---0-0
Net Cash Flow
403.68448.4-288.96-210.63464.74634.79

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
699.07776.72271.54312.921,049277.93
Free Cash Flow Growth
-2.45%186.04%-13.22%-70.17%277.39%-58.25%
Free Cash Flow Margin
19.14%21.96%6.66%6.22%20.35%5.63%
Free Cash Flow Per Share
0.500.550.200.220.750.20
Levered Free Cash Flow
-671.27125.8136.97892.17211.09
Unlevered Free Cash Flow
-671.32125.9137.18892.43211.7
Free Cash Flow After Leases
698.28775.93265.65305.851,043274.38

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
380.87354.24642.78640.21520.63359.93
Change in Working Capital
110.12192.81-186.88-430.84427.52-75.91